½ÃÀ庸°í¼­
»óǰÄÚµå
1453768

¼¼°èÀÇ ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå : ±Ô¸ð ¹× ¿¹Ãø - Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Endoscopy Fluid Management Market Size study & Forecast, by Product, by Application, by End User and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå ±Ô¸ð´Â 2022³â ¾à 8¾ï 840¸¸ ´Þ·¯¿¡ ´ÞÇϰí, ¿¹Ãø ±â°£ÀÎ 2023-2030³â µ¿¾È 7.2% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³»½Ã°æ¿ë À¯Ã¼ °ü¸®´Â ³»½Ã°æ ½Ã¼ú ½Ã »ç¿ëµÇ´Â À¯Ã¼¸¦ È¿°úÀûÀ¸·Î °ü¸®ÇÏ´Â °úÁ¤À» ¸»ÇÕ´Ï´Ù.

³»½Ã°æ °Ë»ç´Â Ä«¸Þ¶ó¿Í ±¤¿øÀÌ ÀåÂøµÈ ±æ°í À¯¿¬ÇÑ Æ©ºê¸¦ ü³»¿¡ »ðÀÔÇÏ¿© Áø´Ü ¹× Ä¡·á ¸ñÀûÀ¸·Î ³»ºÎ Àå±â¿Í Á¶Á÷À» °¡½ÃÈ­ÇÕ´Ï´Ù. ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀåÀº ÃÖ¼Òħ½À ¼ö¼ú ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í À§¾Ï À¯º´·ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¼ÒÈ­°üÀ̳ª Àڱðú °°Àº ü°­¿¡ ¾×ü¸¦ µµÀÔÇÏ¿© °ø°£À» ³ÐÇô ³»ºÎ ±¸Á¶¸¦ ´õ Àß º¼ ¼ö ÀÖµµ·Ï ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ¿¡ µû¶ó 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ±¹Á¦ ½ÃÀå¿¡¼­ ³»½Ã°æ¿ë À¯Ã¼ °ü¸®¿¡ ´ëÇÑ ¼ö¿ä°¡ Á¡Â÷ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖ¼Òħ½À ¼ö¼úÀº ÀϹÝÀûÀ¸·Î Àý°³¸¦ ÁÙÀ̰гª ÀüÇô Àý°³ÇÏÁö ¾Ê±â ¶§¹®¿¡ Á¶Á÷ ¿Ü»óÀÌ ÁÙ¾îµé¾î ȯÀÚÀÇ ÅëÁõÀÌ ÁÙ¾îµé°í ȸº¹ ½Ã°£ÀÌ ´ÜÃàµÇ°í ÇÕº´Áõ °¡´É¼ºÀÌ ³·¾ÆÁý´Ï´Ù. Statista¿¡ µû¸£¸é 2021³â ¼¼°è ÃÖ¼Òħ½À¼ö¼ú ½Ã½ºÅÛ ½ÃÀåÀº 290¾ï ´Þ·¯ ±Ô¸ðÀ̸ç, 2030³â¿¡´Â 550¾ï ´Þ·¯ ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀåÀ» À̲ô´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº À§¾ÏÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. À§¾ÏÀº À§ ³»º®¿¡ º´º¯À̳ª ÀÌ»óÀ» º¸ÀÌ´Â °æ¿ì°¡ ¸¹À¸¸ç, Á¤È®ÇÑ Áø´ÜÀ» À§Çؼ­´Â ³»½Ã°æ °Ë»ç¸¦ ÅëÇÑ ¼±¸íÇÑ ½Ã°¢È­°¡ ÇÊ¿äÇÕ´Ï´Ù. È¿°úÀûÀΠü¾× °ü¸®´Â ±ú²ýÇÏ°í ¼±¸íÇÑ ½Ã¾ß¸¦ º¸ÀåÇÏ°í ³»½Ã°æ Àǻ簡 º´º¯À» Á¤È®ÇÏ°Ô ½Äº°ÇÏ°í Æ¯¼ºÈ­ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹¾ÏÇùȸÀÇ À§¾Ï °ü·Ã ¿¹Ãø¿¡ µû¸£¸é 2024³â±îÁö À§¾ÏÀ¸·Î ÀÎÇÑ ½Å±Ô ȯÀÚ ¼ö´Â ¾à 26,890¸í, À§¾ÏÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â ¾à 1,880¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ³»½Ã°æ °Ë»ç¿¡ ´ëÇÑ ÀÇ»çÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í À¯Ã¼ °ü¸® ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀüÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ³»½Ã°æ ½Ã¼ú°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ³»½Ã°æ¿ë À¯Ã¼ °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä ºÎÁ·Àº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È Àüü ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÔ´Ï´Ù. ºÏ¹Ì°¡ 2022³â ½ÃÀåÀ» ÁÖµµÇÏ´Â ÀÌÀ¯´Â ÀÌ Áö¿ªÀÇ °­·ÂÇÑ ÀÇ·á ÀÎÇÁ¶ó¿Í À§¾Ï ¹ßº´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. °­·ÂÇÑ ÀÇ·á ÀÎÇÁ¶ó´Â Á¾Á¾ ³»½Ã°æ °Ë»ç ÀýÂ÷¿¡ ´ëÇÑ È®¸³µÈ Áöħ°ú Ç¥ÁØÀ» ÁؼöÇϵµ·Ï °­Á¦ÇÕ´Ï´Ù. ¿©±â¿¡´Â ¼ö¾× °ü¸® ÇÁ·ÎÅäÄݵµ Æ÷ÇԵǸç, À§Çè°ú ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇÑ ¸ð¹ü »ç·Ê¸¦ ÁؼöÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ Áö¿ªÀÇ ¾ÐµµÀûÀÎ ½ÇÀûÀº ³»½Ã°æ¿ë À¯Ã¼ °ü¸®¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â À¯Ã¼ °ü¸® ½Ã½ºÅÛÀÇ °³¼±À» Æ÷ÇÔÇÑ ³»½Ã°æ ±â¼úÀÇ ¹ßÀüÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃֽŠ½Ã½ºÅÛÀº º¸´Ù Á¤¹ÐÇÏ°í »ç¿ëÇϱ⠽¬¿ì¸ç ´Ù¾çÇÑ ³»½Ã°æ ½Ã¼úÀÇ Æ¯Á¤ ¿ä±¸¿¡ ¸Â°Ô ¼³°èµÇ¾î ÀÖ½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡º° ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¸î ³â µ¿¾ÈÀÇ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú µµÀü °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°èÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå ¿ªÇÐ

  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • ÃÖ¼Òħ½À ¼ö¼ú ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • À§¾Ï À¯º´·ü Áõ°¡
    • ½ÃÀå °úÁ¦
      • ³»½Ã°æ ¼ö¼ú¿¡ µû¸¥ °íºñ¿ë
      • ³»½Ã°æ¿¡ ÀÇÇÑ À¯Ã¼ °ü¸®¿¡ °üÇÑ ÀÎ½Ä ºÎÁ·
    • ½ÃÀå ±âȸ
      • ³»½Ã°æ °Ë»ç¿¡ °üÇÑ ÀÇ»ç ÀÎ½Ä È®»ê
      • À¯Ã¼ °ü¸® ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸

Á¦4Àå ¼¼°èÀÇ ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
  • Porter's Five Forces ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È¡¤°á·Ð

Á¦5Àå ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : Á¦Ç°º°, ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½Ã½ºÅÛ
    • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ºÎ¼Óǰ

Á¦6Àå ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : ¿ëµµº°, ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • °üÀý°æ °Ë»ç
    • º¹°­°æ °Ë»ç
    • ÀÚ±Ã°æ °Ë»ç
    • ±âŸ

Á¦7Àå ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø
    • Áø·á¼Ò
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ±âŸ

Á¦8Àå ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ¼¼°è ½ÃÀå : Áö¿ª ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï±¹
  • ³»½Ã°æ¿ë À¯Ã¼ °ü¸® ½ÃÀå : Áö¿ª ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç° ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
      • ¿ëµµ ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
      • ÃÖÁ¾»ç¿ëÀÚ ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Stryker Corporation
    • Steris plc
    • Arthrex, Inc.
    • CONMED Corporation
    • Hologic Inc
    • Olympus America Inc.
    • B. Braun SE
    • Medtronic plc
    • Karl Storz Se & Co. KG
    • Comeg Medical Technologies

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 24.04.08

Global Endoscopy Fluid Management Market is valued at approximately USD 808.40 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.2% during the forecast period 2023-2030. Endoscopy Fluid Management refers to the process of effectively managing fluids used during endoscopic procedures. Endoscopy involves inserting a long, flexible tube with a camera and light source into the body to visualize internal organs or tissues for diagnostic or therapeutic purposes. The Endoscopy Fluid Management Market is expanding because of factors such as the rising demand for minimally invasive surgical systems and the increasing prevalence of gastric cancer. Fluid is often introduced into a body cavity, such as the gastrointestinal tract or the uterus, to expand the space and allow better visualization of the internal structures. As a result, the demand for Endoscopy Fluid Management has progressively increased in the international market during the forecast period 2023-2030.

Minimally invasive procedures typically involve smaller incisions or no incisions at all, leading to reduced tissue trauma. This can result in less pain, shorter recovery times, and lower chances of complications for patients. According to Statista, in 2021, the global market for minimally invasive surgical systems accounts for USD 29 billion and is projected to reach over USD 55 billion by the year 2030. Another important factor that drives the Endoscopy Fluid Management Market is the increasing prevalence of gastric cancer. Gastric cancer often presents with lesions or abnormalities in the stomach lining that require clear visualization during endoscopy for accurate diagnosis. Effective fluid management is essential to ensure a clean and clear field of view, allowing the endoscopist to identify and characterize lesions accurately. In addition, as per The American Cancer Society's projections for gastric cancer in the United States, there are about 26,890 new cases of stomach cancer and around 10,880 deaths from gastric cancer by the year 2024. Moreover, growing awareness among physicians regarding endoscopy and technological advancements in fluid management systems are anticipated to create lucrative growth opportunities for the market over the forecast period. However, the high cost associated with endoscopic procedures and lack of awareness regarding endoscopy fluid management is going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Endoscopy Fluid Management Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the strong healthcare infrastructure and increasing cases of stomach cancer in the region. strong healthcare infrastructure often enforces adherence to established guidelines and standards for endoscopy procedures. This includes protocols for fluid management, ensuring that best practices are followed to minimize risks and complications. The region's dominant performance is anticipated to propel the overall demand for Endoscopy Fluid Management. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as growing demand for minimally invasive surgeries in the region. The demand for minimally invasive procedures has driven advancements in endoscopy technology, including improvements in fluid management systems. Modern systems are designed to be more precise, user-friendly, and adaptable to the specific needs of different endoscopic procedures.

Major market player included in this report are:

  • Stryker Corporation
  • STERIS plc
  • Arthrex, Inc.
  • Conmed Corporation
  • Hologic Inc
  • Olympus America Inc.
  • B. Braun SE
  • Medtronic plc
  • Karl Storz Se & Co. KG
  • Comeg Medical Technologies

Recent Developments in the Market:

  • In September 2023, Stryker released the 1788 platform, which is the next generation of minimally invasive surgical cameras. The fully upgraded camera is expected to advance surgery in a variety of disciplines. The all-in-one surgical camera platform produces a more colourful image with balanced illumination, a wider colour gamut, and better delineation of fluorescent signals1. The platform is intended for better visualisation of blood flow and essential anatomy, and it can display several optical imaging agents.

Global Endoscopy Fluid Management Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Application, End User, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product

  • Endoscopy fluid management system
  • Endoscopy fluid management accessories

By Application

  • Arthroscopy
  • Laparoscopy
  • Hysteroscopy
  • Other

By End User

  • Hospitals
  • Clinics
  • Ambulatory surgical centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1.Endoscopy Fluid Management Market, by Region, 2020-2030 (USD Million)
    • 1.2.2.Endoscopy Fluid Management Market, by Product, 2020-2030 (USD Million)
    • 1.2.3.Endoscopy Fluid Management Market, by Application, 2020-2030 (USD Million)
    • 1.2.4.Endoscopy Fluid Management Market, by End User, 2020-2030 (USD Million)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Endoscopy Fluid Management Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Endoscopy Fluid Management Market Dynamics

  • 3.1.Endoscopy Fluid Management Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Rising demand for minimally invasive surgical system
      • 3.1.1.2.Increasing prevalence of gastric cancer
    • 3.1.2.Market Challenges
      • 3.1.2.1.High cost associated with endoscopic procedures
      • 3.1.2.2.Lack of awareness regarding endoscopy fluid management
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Growing awareness among physicians regarding endoscopy
      • 3.1.3.2.Technological advancements in fluid management systems

Chapter 4.Global Endoscopy Fluid Management Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Endoscopy Fluid Management Market, by Product

  • 5.1.Market Snapshot
  • 5.2.Global Endoscopy Fluid Management Market by Product, Performance - Potential Analysis
  • 5.3.Global Endoscopy Fluid Management Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4.Endoscopy Fluid Management Market, Sub Segment Analysis
    • 5.4.1.Endoscopy fluid management system
    • 5.4.2.Endoscopy fluid management accessories

Chapter 6.Global Endoscopy Fluid Management Market, by Application

  • 6.1.Market Snapshot
  • 6.2.Global Endoscopy Fluid Management Market by Application, Performance - Potential Analysis
  • 6.3.Global Endoscopy Fluid Management Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 6.4.Endoscopy Fluid Management Market, Sub Segment Analysis
    • 6.4.1.Arthroscopy
    • 6.4.2.Laparoscopy
    • 6.4.3.Hysteroscopy
    • 6.4.4.Others

Chapter 7.Global Endoscopy Fluid Management Market, by End User

  • 7.1.Market Snapshot
  • 7.2.Global Endoscopy Fluid Management Market by End User, Performance - Potential Analysis
  • 7.3.Global Endoscopy Fluid Management Market Estimates & Forecasts by End User 2020-2030 (USD Million)
  • 7.4.Endoscopy Fluid Management Market, Sub Segment Analysis
    • 7.4.1.Hospitals
    • 7.4.2.Clinics
    • 7.4.3.Ambulatory surgical centers
    • 7.4.4.Others

Chapter 8.Global Endoscopy Fluid Management Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Endoscopy Fluid Management Market, Regional Market Snapshot
  • 8.4.North America Endoscopy Fluid Management Market
    • 8.4.1.U.S. Endoscopy Fluid Management Market
      • 8.4.1.1.Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.End User breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Endoscopy Fluid Management Market
  • 8.5.Europe Endoscopy Fluid Management Market Snapshot
    • 8.5.1.U.K. Endoscopy Fluid Management Market
    • 8.5.2.Germany Endoscopy Fluid Management Market
    • 8.5.3.France Endoscopy Fluid Management Market
    • 8.5.4.Spain Endoscopy Fluid Management Market
    • 8.5.5.Italy Endoscopy Fluid Management Market
    • 8.5.6.Rest of Europe Endoscopy Fluid Management Market
  • 8.6.Asia-Pacific Endoscopy Fluid Management Market Snapshot
    • 8.6.1.China Endoscopy Fluid Management Market
    • 8.6.2.India Endoscopy Fluid Management Market
    • 8.6.3.Japan Endoscopy Fluid Management Market
    • 8.6.4.Australia Endoscopy Fluid Management Market
    • 8.6.5.South Korea Endoscopy Fluid Management Market
    • 8.6.6.Rest of Asia Pacific Endoscopy Fluid Management Market
  • 8.7.Latin America Endoscopy Fluid Management Market Snapshot
    • 8.7.1.Brazil Endoscopy Fluid Management Market
    • 8.7.2.Mexico Endoscopy Fluid Management Market
  • 8.8.Middle East & Africa Endoscopy Fluid Management Market
    • 8.8.1.Saudi Arabia Endoscopy Fluid Management Market
    • 8.8.2.South Africa Endoscopy Fluid Management Market
    • 8.8.3.Rest of Middle East & Africa Endoscopy Fluid Management Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
    • 9.1.1.Company 1
    • 9.1.2.Company 2
    • 9.1.3.Company 3
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Stryker Corporation
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2.Steris plc
    • 9.3.3.Arthrex, Inc.
    • 9.3.4.CONMED Corporation
    • 9.3.5.Hologic Inc
    • 9.3.6.Olympus America Inc.
    • 9.3.7.B. Braun SE
    • 9.3.8.Medtronic plc
    • 9.3.9.Karl Storz Se & Co. KG
    • 9.3.10.Comeg Medical Technologies

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦